ConductScience.org, home

Paper41998221

Semaphorin 4D (CD100) expression as a predictor for the response to induction therapy in pediatric patients with B-acute lymphoblastic leukemia.

Elkholy RA and 6 others. Eur J Pediatr, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Semaphorin 4D (CD100) expression as a predictor for the response to induction therapy in pediatric patients with B-acute lymphoblastic leukemia. Papers, record 41998221. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41998221

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Semaphorin 4D (CD100) expression as a predictor for the response to induction therapy in pediatric patients with B-acute lymphoblastic leukemia.
PubMed
Journal
Eur J Pediatr
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-21
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Elkholy RARasha A
2El Amrousy DDoaa
3Elgezawy DEDoaa E
4Elkholy RAReem A
5Taha OOla
6Eltoukhy AAAbeer A
7Elaskary EEman

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SemaphorinsMajor topic
Antigens, CDMajor topic
Induction ChemotherapyMajor topic
Biomarkers, TumorMajor topic
Precursor B-Cell Lymphoblastic Leukemia-LymphomaMajor topic
Precursor Cell Lymphoblastic Leukemia-LymphomaMajor topic
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Humans
Child
Male
Female
Child, Preschool
Prognosis
Adolescent
ROC Curve
Flow Cytometry
Treatment Outcome
Infant
Leukocytes, Mononuclear

Source PubMed

Download CSV of topics

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127912840The semaphorins and their receptors as modulators of tumor progression.Drug Resist Updat2016https://conductscience.org/library/papers/27912840PubMed
212123608Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology.Neuron2002https://conductscience.org/library/papers/12123608PubMed
335269896Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children.Int J Mol Sci2022https://conductscience.org/library/papers/35269896PubMed
435401878Soluble Sema4D Level Is Positively Correlated with Sema4D Expression in PBMCs and Peripheral Blast Number in Acute Leukemia.Dis Markers2022https://conductscience.org/library/papers/35401878PubMed
515124703Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia.Ann Hematol2004https://conductscience.org/library/papers/15124703PubMed
624572378Survival improvement by decade of patients aged 0-14 years with acute lymphoblastic leukemia: a SEER analysis.Sci Rep2014https://conductscience.org/library/papers/24572378PubMed
714692523Acute myelogenous leukemia with t(8;21)--identification of a specific immunophenotype.Leuk Lymphoma2003https://conductscience.org/library/papers/14692523PubMed
811114375Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling.Immunity2000https://conductscience.org/library/papers/11114375PubMed
912133937Requirement for the lymphocyte semaphorin, CD100, in the induction of antigen-specific T cells and the maturation of dendritic cells.J Immunol2002https://conductscience.org/library/papers/12133937PubMed
1027022279The role of semaphorin 4D as a potential biomarker for antiangiogenic therapy in colorectal cancer.Onco Targets Ther2016https://conductscience.org/library/papers/27022279PubMed
1110982779The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis.Gastroenterology2000https://conductscience.org/library/papers/10982779PubMed
1212094248Antigen expression patterns reflecting genotype of acute leukemias.Leukemia2002https://conductscience.org/library/papers/12094248PubMed
1327729799The role of semaphorin 4D in tumor development and angiogenesis in human breast cancer.Onco Targets Ther2016https://conductscience.org/library/papers/27729799PubMed
1431819303Frequency of Cytogenetic Findings and its Effect on the Outcome of Pediatric Acute Lymphoblastic Leukemia.Med Arch2019https://conductscience.org/library/papers/31819303PubMed
1511369643Functional soluble CD100/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses.Blood2001https://conductscience.org/library/papers/11369643PubMed
1628816021CD155 knockdown promotes apoptosis via AKT/Bcl-2/Bax in colon cancer cells.J Cell Mol Med2018https://conductscience.org/library/papers/28816021PubMed
174179068Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.Scand J Clin Lab Invest Suppl1968https://conductscience.org/library/papers/4179068PubMed
1814534257The transmembrane semaphorin Sema4D/CD100, an inhibitor of axonal growth, is expressed on oligodendrocytes and upregulated after CNS lesion.J Neurosci2003https://conductscience.org/library/papers/14534257PubMed
1935794581SEMA4D/PlexinB1 promotes AML progression via activation of PI3K/Akt signaling.J Transl Med2022https://conductscience.org/library/papers/35794581PubMed
2017855350Plexin-B1 utilizes RhoA and Rho kinase to promote the integrin-dependent activation of Akt and ERK and endothelial cell motility.J Biol Chem2007https://conductscience.org/library/papers/17855350PubMed

See all 26 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SEMA4D10507PubTator's text mininghttps://conductscience.org/library/genes/10507

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41998221

GET https://conductscience.org/api/papers/v1/41998221/references?page=2